Your browser doesn't support javascript.
loading
Application of desirability of outcome ranking to the milking in non-vigorous infants trial.
Katheria, Anup C; El Ghormli, Laure; Rice, Madeline M; Dorner, Rebecca A; Grobman, William A; Evans, Scott R.
Afiliación
  • Katheria AC; Neonatal Research Institute, Sharp Mary Birch Hospital for Women & Newborns, San Diego, CA, United States of America. Electronic address: anup.katheria@sharp.com.
  • El Ghormli L; George Washington University Biostatistics Center, Washington, DC, United States of America.
  • Rice MM; George Washington University Biostatistics Center, Washington, DC, United States of America.
  • Dorner RA; Neonatal Research Institute, Sharp Mary Birch Hospital for Women & Newborns, San Diego, CA, United States of America.
  • Grobman WA; Department of Obstetrics, Ohio State University, Columbus, OH, United States of America.
  • Evans SR; George Washington University Biostatistics Center, Washington, DC, United States of America.
Early Hum Dev ; 189: 105928, 2024 Feb.
Article en En | MEDLINE | ID: mdl-38211436
ABSTRACT

OBJECTIVES:

Neonatal trials have traditionally used binary composite short-term (such as death or bronchopulmonary dysplasia) or longer-term (such as death or severe neurodevelopmental impairment) outcomes. We applied the Desirability Of Outcome Ranking (DOOR) method to rank the overall patient outcome by best (no morbidities) to worst (death). STUDY

DESIGN:

Using a completed large multicenter trial (Milking In Non-Vigorous Infants [MINVI]) of umbilical cord milking (UCM) vs. early cord clamping (ECC), we applied the DOOR methodology to neonatal outcomes. Six outcomes were chosen and ranked no interventions or NICU admission (most desirable); received initial cardiorespiratory support at birth; neonatal intensive care unit (NICU) admission for predefined criteria; mild hypoxic-ischemic encephalopathy (HIE); moderate to severe HIE; and death (least desirable).

RESULTS:

1524 non-vigorous newborns born between 35 and 42 weeks' gestation had data for analysis. The DOOR distribution was different between the UCM and ECC arms, with a significantly greater probability (55.8 % [95 % CI 53.1-58.5 %; p < 0.0001]) of a randomly selected neonate having a more desirable outcome if they were in the UCM arm. DOOR probabilities of averting individual adverse outcomes such as NICU admission for predefined criteria (52.8 %; 95%CI 50.5-55.1 %) and cardiorespiratory support (54.0 %; 95%CI 51.6-56.4 %) were significantly higher among those in the UCM group.

CONCLUSION:

DOOR provides an overall assessment of the benefits and harms with greater insight than typical binary composite measures to clinicians and parents when evaluating an intervention. Future neonatal trials should consider the a priori use of the DOOR methodology to evaluate trial outcomes.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cordón Umbilical / Recien Nacido Prematuro Tipo de estudio: Clinical_trials Límite: Humans / Infant / Newborn Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cordón Umbilical / Recien Nacido Prematuro Tipo de estudio: Clinical_trials Límite: Humans / Infant / Newborn Idioma: En Año: 2024 Tipo del documento: Article